| Bioactivity | Ranevetmab (NV-01) is a caninised anti-NGF monoclonal antibody (mAb). Ranevetmab can alleviate pain, and is used for the research of degenerative joint disease (DJD) pain[1]. |
| In Vivo | Ranevetmab (200 μg/kg，静脉注射) 减轻狗的退行性关节病 (DJD) 疼痛[1]。 Animal Model: |
| Name | Ranevetmab |
| CAS | 1632282-27-9 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lascelles BD, et al. A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain. BMC Vet Res. 2015 Apr 30;11:101. |